Co-Authors
This is a "connection" page, showing publications co-authored by Xinghuan Wang and Fuling Zhou.
Connection Strength
2.307
-
Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus. Front Immunol. 2021; 12:580147.
Score: 0.235
-
Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study. Virulence. 2020 12; 11(1):1569-1581.
Score: 0.229
-
Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey. EClinicalMedicine. 2020 Sep; 26:100510.
Score: 0.226
-
Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19. J Med Virol. 2021 02; 93(2):612-614.
Score: 0.225
-
Prominent Hypercoagulability Associated With Inflammatory State Among Cancer Patients With SARS-CoV-2 Infection. Front Oncol. 2020; 10:1345.
Score: 0.223
-
Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine. 2020 Jul; 24:100426.
Score: 0.223
-
Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments. Ann Hematol. 2020 08; 99(8):1933-1938.
Score: 0.222
-
Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19. Int J Cancer. 2020 12 01; 147(11):3267-3269.
Score: 0.222
-
Recurrent positive SARS-CoV-2: Immune certificate may not be valid. J Med Virol. 2020 11; 92(11):2384-2386.
Score: 0.222
-
Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19. Front Med (Lausanne). 2020; 7:246.
Score: 0.221
-
Relationship Between Serum Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid and Organ Damage in Coronavirus 2019 Patients: A Cohort Study. Clin Infect Dis. 2021 07 01; 73(1):68-75.
Score: 0.060